Identifi is a comprehensive genomic testing platform from HaystackAnalytics Private Limited, built to aid the diagnosis, screening, and management of genetic disorders using advanced Next-Generation Sequencing (NGS) technology. The platform delivers genomic insights into inherited conditions, rare genetic disorders, and pharmacogenomic variations, enabling healthcare professionals to make well-informed decisions about patient care.
By examining an individual's genetic information, Identifi pinpoints clinically relevant genetic variants linked to inherited diseases and to differences in drug response. Its testing solutions advance personalised healthcare by offering insights into genetic predispositions, disease risks, and how a patient may respond to medications.
Identifi provides specialised genomic testing in areas such as paediatric genetics, inherited disorders, and pharmacogenomics. These solutions help clinicians understand the genetic basis of certain conditions and choose more personalised treatment approaches.
With a focus on precision medicine, advanced genomic technologies, and accessible genetic testing, Identifi aims to close the gap between genomic research and clinical practice. Through its Pan-India sample collection network and wide-ranging testing capabilities, Identifi by HaystackAnalytics is working to make personalised, evidence-based healthcare more accessible.
DGx cardio, DGx pediatrics, PGx comprehensive, PGx oncology, HAT
-